🔗 Share this article

Chancellor Reeves has announced she is preparing "focused measures to deal with household expense issues" in the upcoming Budget.

In comments to media outlets, she stated that reducing price rises is a collective task of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 developed nations this year and next.

Possible Utility Cost Measures

Sources suggest the administration could take action to bring down energy bills, for example by reducing the present 5% rate of VAT charged on energy supplies.

Another possibility is to lower some of the government charges presently included in household expenses.

Budgetary Constraints and Analyst Expectations

The government will obtain the next report from the official forecaster, the OBR, on Monday, which will reveal how much space there is for these actions.

The view from the majority of experts is that Reeves will have to introduce higher taxes or budget cuts in order to fulfill her declared borrowing rules.

Earlier on Thursday, estimates indicated there was a £22bn deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"It is a joint task between the central bank and the administration to further reduce some of the causes of price increases," Reeves informed the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Issues

While a great deal of the attention has been on likely tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not altered her commitment to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with growing international and trade concerns for the Budget revenue measures, probably to be targeted on those "wealthiest."

International Economic Disputes

Commenting on apprehensions about the UK's trade ties with the Asian nation she said: "Our security interests invariably are paramount."

Last week's statement by Chinese authorities to strengthen export controls on critical minerals and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to suggest an further 100% tariff on imports from the Asian country, raising the risk of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary described China's move "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "bad for the international commerce and creates additional challenges."

"I believe there are sectors where we must challenge Chinese policies, but there are also significant prospects to trade with Chinese markets, including financial services and other sectors of the economy. We've got to achieve that equilibrium right."

The chancellor also stated she was cooperating with G7 counterparts "on our own essential resources plan, so that we are less reliant."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the National Health Service spends on medicines could increase as a consequence of current discussions with the US government and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or abandoning investments in the United Kingdom, with some attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the price the NHS spends on drugs would must go up to prevent businesses and pharmaceutical investment departing from the UK.

The Chancellor stated to media: "It has been observed due to the pricing regime, that clinical trials, recent pharmaceuticals have not been available in the UK in the manner that they are in other European countries."

"The objective is to ensure that individuals receiving treatment from the National Health Service are able to receive the top essential drugs in the globe. And so we are reviewing this situation, and... seeking to secure increased capital into the UK."